CVRx, Inc. Operating Expenses
CVRx, Inc. (CVRX) reported Operating Expenses of $26.75 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- CVRx, Inc. operating expenses for the quarter ending 2026-06-30 was $26.75M, a 3.57% increase year-over-year.
- CVRx, Inc. operating expenses for the quarter ending 2026-03-31 was $25.04M, a 5.44% increase year-over-year.
- CVRx, Inc. operating expenses for the quarter ending 2025-12-31 was $25.01M, a 8.52% increase year-over-year.
- CVRx, Inc. operating expenses for the quarter ending 2025-09-30 was $25.02M, a 3.67% increase year-over-year.
- CVRx, Inc. operating expenses for fiscal 2025 was $99.61M, a 2.78% decline from fiscal 2024.
- CVRx, Inc. operating expenses for fiscal 2024 was $102.45M, a 34.55% increase from fiscal 2023.
- CVRx, Inc. operating expenses for fiscal 2023 was $76.14M, a 26.91% increase from fiscal 2022.
- CVRx, Inc. operating expenses for fiscal 2022 was $60.00M, a 69.66% increase from fiscal 2021.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $26.75M 10-Q · filed 2026-08-06 | $51.79M 10-Q · filed 2026-08-06 | $76.80M derived: sum of 3 quarters · filed 2026-08-06 | $101.82M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $25.04M 10-Q · filed 2026-05-12 | $50.05M derived: sum of 2 quarters · filed 2026-05-12 | $75.07M derived: sum of 3 quarters · filed 2026-05-12 | $100.90M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $25.01M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $50.03M derived: sum of 2 quarters · filed 2026-02-13 | $75.86M derived: sum of 3 quarters · filed 2026-08-06 | $99.61M 10-K · filed 2026-02-13 |
| 2025-09-30 | $25.02M 10-Q · filed 2025-11-06 | $50.85M derived: sum of 2 quarters · filed 2026-08-06 | $74.60M 10-Q · filed 2025-11-06 | $97.64M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $25.83M 10-Q · filed 2026-08-06 | $49.58M 10-Q · filed 2026-08-06 | $72.62M derived: sum of 3 quarters · filed 2026-08-06 | $96.76M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $23.75M 10-Q · filed 2026-05-12 | $46.79M derived: sum of 2 quarters · filed 2026-05-12 | $70.93M derived: sum of 3 quarters · filed 2026-05-12 | $94.81M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $23.05M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13 | $47.18M derived: sum of 2 quarters · filed 2026-02-13 | $71.06M derived: sum of 3 quarters · filed 2026-02-13 | $102.45M 10-K · filed 2026-02-13 |
| 2024-09-30 | $24.14M 10-Q · filed 2025-11-06 | $48.02M derived: sum of 2 quarters · filed 2025-11-06 | $79.40M 10-Q · filed 2025-11-06 | $98.65M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $23.88M 10-Q · filed 2025-08-05 | $55.27M 10-Q · filed 2025-08-05 | $74.51M derived: sum of 3 quarters · filed 2025-08-05 | $92.86M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $31.39M 10-Q · filed 2025-05-09 | $50.63M derived: sum of 2 quarters · filed 2025-05-09 | $68.98M derived: sum of 3 quarters · filed 2025-05-09 | $88.72M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | $19.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18 | $37.59M derived: sum of 2 quarters · filed 2025-02-18 | $57.33M derived: sum of 3 quarters · filed 2025-02-18 | $76.14M 10-K · filed 2025-02-18 |
| 2023-09-30 | $18.35M 10-Q · filed 2024-11-01 | $38.08M derived: sum of 2 quarters · filed 2024-11-01 | $56.90M 10-Q · filed 2024-11-01 | $74.04M derived: sum of 4 quarters · filed 2024-11-01 |
| 2023-06-30 | $19.73M 10-Q · filed 2024-08-02 | $38.55M 10-Q · filed 2024-08-02 | $55.69M derived: sum of 3 quarters · filed 2024-08-02 | $70.67M derived: sum of 4 quarters · filed 2024-08-02 |
| 2023-03-31 | $18.81M 10-Q · filed 2024-05-10 | $35.96M derived: sum of 2 quarters · filed 2024-05-10 | $50.93M derived: sum of 3 quarters · filed 2024-05-10 | $65.78M derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | $17.15M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-09 | $32.12M derived: sum of 2 quarters · filed 2024-02-09 | $46.96M derived: sum of 3 quarters · filed 2024-02-09 | $60.00M 10-K · filed 2024-02-09 |
| 2022-09-30 | $14.97M 10-Q · filed 2023-10-31 | $29.82M derived: sum of 2 quarters · filed 2023-10-31 | $42.85M 10-Q · filed 2023-10-31 | $54.31M derived: sum of 4 quarters · filed 2023-10-31 |
| 2022-06-30 | $14.84M 10-Q · filed 2023-08-03 | $27.88M 10-Q · filed 2023-08-03 | $39.34M derived: sum of 3 quarters · filed 2023-08-03 | $49.15M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $13.04M 10-Q · filed 2023-05-11 | $24.50M derived: sum of 2 quarters · filed 2023-05-11 | $34.31M derived: sum of 3 quarters · filed 2023-05-11 | $42.19M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $11.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $21.27M derived: sum of 2 quarters · filed 2023-02-10 | $29.15M derived: sum of 3 quarters · filed 2023-02-10 | $35.36M 10-K · filed 2023-02-10 |
| 2021-09-30 | $9.81M 10-Q · filed 2022-11-04 | $17.69M derived: sum of 2 quarters · filed 2022-11-04 | $23.90M 10-Q · filed 2022-11-04 | $27.67M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $7.88M 10-Q · filed 2022-08-01 | $14.09M 10-Q · filed 2022-08-01 | $17.86M derived: sum of 3 quarters · filed 2022-08-01 | $21.69M derived: sum of 4 quarters · filed 2022-08-01 |
| 2021-03-31 | $6.21M 10-Q · filed 2022-05-02 | $9.98M derived: sum of 2 quarters · filed 2022-05-02 | $13.81M derived: sum of 3 quarters · filed 2022-05-02 | $17.77M derived: sum of 4 quarters · filed 2022-05-02 |
| 2020-12-31 | $3.77M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $7.60M derived: sum of 2 quarters · filed 2022-02-22 | $11.56M derived: sum of 3 quarters · filed 2022-02-22 | $16.13M 10-K · filed 2022-02-22 |
| 2020-09-30 | $3.83M 10-Q · filed 2021-11-08 | $7.79M derived: sum of 2 quarters · filed 2021-11-08 | $12.36M 10-Q · filed 2021-11-08 | |
| 2020-06-30 | $3.96M 10-Q · filed 2021-08-09 | $8.53M 10-Q · filed 2021-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |